Ha G, Kwong K, Tanaka B, Nishimura Y, Chong C. Are patients with HHV-8 associated Castleman disease successfully treated with rituximab at risk of subsequently developing HHV-8 negative (idiopathic) Castleman disease? iMCD after HHV-8-associated MCD. EJCRIM 2023;10 doi:10.12890/2023_003904.